---
figid: PMC5571607__13014_2017_865_Fig2_HTML
figlink: /pmc/articles/PMC5571607/figure/Fig2/
number: Fig. 2
caption: Schematic illustration of DAMP/ TLR/ inflammasome interactions. Damage-induced
  release of damage associated molecular patterns (DAMPs) into the extracellular region
  can result in ligand binding to specific receptors or uptake in diverse target cells.
  TOLL-like receptor (TLR)-binding and recruitment of the adaptor protein MyD88 leads
  to subsequent activation of TNF receptor associated factor (TRAF) 6 in the cytosol.
  Activation of the IKK kinase complex or mitogen-activated protein kinase (MAPKs)
  result in the translocation of the transcription factors nuclear factor kappa B
  (NF-κB) and activator protein 1 (AP-1) into the nucleus respectively. In the nucleus
  they induce the expression of pro-inflammatory cytokines like pro-IL-1β/ IL-18.
  TLR4 internalization will induce a switch from MyD88 to TIR-domain-containing adapter-inducing
  interferon-β (TRIF) signaling [, ]. The recruitment of TRIF results in signaling
  cascades similar to the ones described for the MyD88 pathway. On the one hand, TRIF
  can either interact with TRAF6 resulting in NFκB-dependent or AP-1 dependent production
  of inflammatory cytokines. In addition, TRIF can also interact with TRAF3 leading
  to the induction of the transcription factors Interferon regulatory factor (IRF)3/7.
  Translocation of IRF3/7 into the nucleus then triggers the production of type 1
  interferons [–]. Furthermore, reactive oxygen species (ROS) and DAMPs can induce
  the activation of the NLR family, pyrin domain-containing 3 (NLRP3) inflammasome
  complex and subsequent caspase-1 activation, capable of cleaving pro-IL-1β and pro-IL-18
  into mature and secreted IL-1β and IL-18. Nucleotides like ATP, ADP, AMP and the
  nucleoside adenosine can bind to its purino-receptors like P2XR, P2YR and P1R, respectively,
  thereby triggering the activation of the NLRP3 inflammasome complex. Additionally,
  intracellular DAMP (e.g. uric acid) uptake into phagosomes, lysosomal damage or
  specific binding of e.g. hyaluronan to the CD44 receptor can further activate the
  NLRP3 inflammasome complex, promoting inflammation
pmcid: PMC5571607
papertitle: 'Modeling DNA damage-induced pneumopathy in mice: insight from danger
  signaling cascades.'
reftext: Florian Wirsdörfer, et al. Radiat Oncol. 2017;12:142.
pmc_ranked_result_index: '145375'
pathway_score: 0.9557897
filename: 13014_2017_865_Fig2_HTML.jpg
figtitle: DAMP/ TLR/ inflammasome interactions
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5571607__13014_2017_865_Fig2_HTML.html
  '@type': Dataset
  description: Schematic illustration of DAMP/ TLR/ inflammasome interactions. Damage-induced
    release of damage associated molecular patterns (DAMPs) into the extracellular
    region can result in ligand binding to specific receptors or uptake in diverse
    target cells. TOLL-like receptor (TLR)-binding and recruitment of the adaptor
    protein MyD88 leads to subsequent activation of TNF receptor associated factor
    (TRAF) 6 in the cytosol. Activation of the IKK kinase complex or mitogen-activated
    protein kinase (MAPKs) result in the translocation of the transcription factors
    nuclear factor kappa B (NF-κB) and activator protein 1 (AP-1) into the nucleus
    respectively. In the nucleus they induce the expression of pro-inflammatory cytokines
    like pro-IL-1β/ IL-18. TLR4 internalization will induce a switch from MyD88 to
    TIR-domain-containing adapter-inducing interferon-β (TRIF) signaling [, ]. The
    recruitment of TRIF results in signaling cascades similar to the ones described
    for the MyD88 pathway. On the one hand, TRIF can either interact with TRAF6 resulting
    in NFκB-dependent or AP-1 dependent production of inflammatory cytokines. In addition,
    TRIF can also interact with TRAF3 leading to the induction of the transcription
    factors Interferon regulatory factor (IRF)3/7. Translocation of IRF3/7 into the
    nucleus then triggers the production of type 1 interferons [–]. Furthermore, reactive
    oxygen species (ROS) and DAMPs can induce the activation of the NLR family, pyrin
    domain-containing 3 (NLRP3) inflammasome complex and subsequent caspase-1 activation,
    capable of cleaving pro-IL-1β and pro-IL-18 into mature and secreted IL-1β and
    IL-18. Nucleotides like ATP, ADP, AMP and the nucleoside adenosine can bind to
    its purino-receptors like P2XR, P2YR and P1R, respectively, thereby triggering
    the activation of the NLRP3 inflammasome complex. Additionally, intracellular
    DAMP (e.g. uric acid) uptake into phagosomes, lysosomal damage or specific binding
    of e.g. hyaluronan to the CD44 receptor can further activate the NLRP3 inflammasome
    complex, promoting inflammation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRAF6
  - IFNA8
  - IFNA5
  - IFNA7
  - IFNA1
  - IFNA2
  - IFNA6
  - TLR4
  - IFNK
  - IRAK1
  - IFNA4
  - IFNW1
  - IL18
  - IFNA17
  - IRAK2
  - TLR2
  - JUN
  - JUNB
  - IFNA21
  - IFNB1
  - IL1B
  - MFAP1
  - JUND
  - FOSL1
  - FOSL2
  - WDTC1
  - FOS
  - FOSB
  - TIRAP
  - ADO
  - IKBKG
  - IFNA14
  - IFNA16
  - IRF7
  - IL1A
  - IRF3
  - NLRP3
  - HMGB1
  - RPL18
  - IFNA13
  - IKBKB
  - IFNA10
  - CD44
  - CHUK
  - MYD88
  - Uric acid
genes:
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: TLR2/4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNK
  entrez: '56832'
- word: IRAK1/2
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNW1
  entrez: '3467'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: IRAK1/2
  symbol: IRAK2
  source: hgnc_symbol
  hgnc_symbol: IRAK2
  entrez: '3656'
- word: TLR2/4
  symbol: TLR2
  source: hgnc_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: TIRAP
  symbol: TIRAP
  source: hgnc_symbol
  hgnc_symbol: TIRAP
  entrez: '114609'
- word: +ADO
  symbol: ADO
  source: hgnc_symbol
  hgnc_symbol: ADO
  entrez: '84890'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: HMGB1
  symbol: HMGB1
  source: hgnc_symbol
  hgnc_symbol: HMGB1
  entrez: '3146'
- word: L-18
  symbol: L18
  source: hgnc_alias_symbol
  hgnc_symbol: RPL18
  entrez: '6141'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: CD44
  symbol: CD44
  source: hgnc_symbol
  hgnc_symbol: CD44
  entrez: '960'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
chemicals:
- word: Uric acid
  source: MESH
  identifier: D014527
diseases: []
---
